These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 471751)

  • 1. [The phenomenon of nuclear refringence. Method of evaluation of immune deficit in cancer patients].
    Pompidou A; Mace B; Lerolle PF; François M; Cerbonnet G
    Nouv Presse Med; 1979 May; 8(22):1856. PubMed ID: 471751
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential action of mitogens on human lymphocytes from cancer patients.
    Nag S; Sharma A; Talukder G
    Indian J Pathol Microbiol; 1983 Jul; 26(3):145-51. PubMed ID: 6365761
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the immune function of patients undergoing radiotherapy: results after 18 months].
    Monti G; Guerrini L; Magni E; Sama D; Serafini M; Bardella D
    Boll Ist Sieroter Milan; 1985; 64(2):142-5. PubMed ID: 4027019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell-mediated immunity in patients with oral cancer. I: Correlation of peripheral lymphocyte reactivity with the clinical status of untreated patients].
    Seyama A
    Hiroshima Daigaku Shigaku Zasshi; 1982; 14(2):156-66. PubMed ID: 6963292
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell-mediated immunity in patients with oral cancer. II: Correlation of peripheral lymphocyte reactivity with the clinical course].
    Seyama A
    Hiroshima Daigaku Shigaku Zasshi; 1982; 14(2):167-74. PubMed ID: 6963293
    [No Abstract]   [Full Text] [Related]  

  • 7. A formula to assess lymphocyte responsiveness in vitro.
    Hosking CS; Balloch A
    Birth Defects Orig Artic Ser; 1983; 19(3):21-3. PubMed ID: 6360234
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and basic research on protein polysaccharide, PS-K (author's transl)].
    Mugitani H; Naruki Y; Matsuo K; Yoshida M; Ohtsuka S; Satake K; Motoki N; Kakihara U; Sugawara M; Kaneda K; Shinbo T; Yata J
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):812-8. PubMed ID: 315442
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.
    Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD
    J Med; 1974; 5(1):92-7. PubMed ID: 4275505
    [No Abstract]   [Full Text] [Related]  

  • 11. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
    Kowalczyk D; Zembala M; Popiela T; Labza H
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of undernutrition and disease site and stage on cell-mediated immunity in gastrointestinal cancer.
    Burke M; Hesp R; Kark AE
    Clin Oncol; 1983 Sep; 9(3):203-11. PubMed ID: 6616994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune response in cancer by plasma: the postulated role of transcortin.
    Amaral L; Werthamer S
    Ann Clin Lab Sci; 1974; 4(6):435-40. PubMed ID: 4429341
    [No Abstract]   [Full Text] [Related]  

  • 14. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunity and malignant neoplasms. Correlation among various immunologic tests].
    Hortells Aznar JL; Faure Nogueras E; Gutiérrez Martín M; Martínez Taberniero R; Tres Sánchez A; Romero Colas MS
    Rev Clin Esp; 1982 Sep; 166(5):199-202. PubMed ID: 6755572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of cellular immunity by the nuclear refringence test during general anesthesia].
    Pompidou A; Barbet JP; Moisson MT; Landais A
    Ann Anesthesiol Fr; 1981; 22(3):235-7. PubMed ID: 6170239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on cellular immunity of cancer patients treated with BCG.
    Onami K; Nanamiya M; Ohara M; Yoshida H; Kasukawa R
    Fukushima J Med Sci; 1982; 28(3-4):119-28. PubMed ID: 7186871
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Quantitation of immunologic defects in cancer patients.
    Chretien PB; Ketcham AS
    Proc Natl Cancer Conf; 1972; 7():187-92. PubMed ID: 4764900
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Mechanism in reduced cellular immunity in cancer patients].
    Nagai T; Kondo A; Yoshida N; Atomachi Y
    Hokkaido Igaku Zasshi; 1975 Jan; 50(1):85-6. PubMed ID: 1171070
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
    Blomgren H; Strender LE; Edsmyr F
    Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.